NEW YORK, NY / ACCESSWIRE / February 4, 2016 / Moments ago, Trader's Choice released new research updates concerning several developing situations, including one of the leading uptrends in today's market: XLI Technologies, Inc. (XLIT) – currently up 44.5% within the past 2 weeks.
XLIT's growth appears to be buoyed by a recently published research report, which highlights "[XLIT's technology] could display LEDs in an astounding array of uses."
The report placed a $7.43 target on XLIT and can be viewed here: http://bit.ly/XLITreport
=========
Defining Success and Seeking Opportunity
Even though Trader's Choice may make it look easy, discovering emerging growth situations such as XLIT is no walk in the park. It requires the perfect marriage of fundamental value, technical triggers, market opportunity, industry climate and most importantly – informational advantage. Each month, Trader's Choice obtains this edge by reviewing thousands of publicly traded companies and actually screens hundreds of thousands of SEC filings in search of the next great emerging stock play.
=========
Today, Trader's Choice has made its recent analyst notes on General Electric Co. (NYSE: GE), Dow Chemical Co. (NYSE: DOW), Bristol-Myers Squibb Co. (NYSE: BMY) and Eli Lilly and Co. (NYSE: LLY) available to the public for informational purposes only. To receive further updates on some of the best opportunities available in the market, readers may secure a complementary subscription at: http://www.traders-choice.com/freevip
Analyst Notes on GE
- General Electric Co.'s stock edged higher by 1.52% to close Wednesday's session at USD 28.67. The stock closed below its 50-day moving average of USD 29.44 while closing above its 200-day moving average of USD 27.88. The company's shares oscillated between USD 27.87 and USD 28.69. The stock recorded a trading volume of 44.26 million shares, which was below its 50-day daily average volume of 61.06 million shares and its 52-week average volume of 53.75 million shares. Over the last three days General Electric Co.'s shares have declined by 1.48% whereas in the past one week the stock has moved up 2.39%. Further, the stock is trading at a price to book ratio of 2.90, compared to its historical PB ratio of 3.20. Additionally, the company is trading at a price to cash flow ratio of 10.71 and a price to sales ratio of 2.43
- Based on initial review, further research is warranted into GE for discovery of potential future opportunity.
Analyst Notes on DOW
- The stock of Dow Chemical Co. gained 3.80% to close Wednesday's session at USD 46.74. The shares of the company moved in the range of USD 45.70 and USD 47.05. A trading volume of 16.75 million shares was recorded, which was greater than its 150-day daily average volume of 12.50 million shares and its 52-week average volume of 10.61 million shares. Over the last five days Dow Chemical Co.'s shares have advanced 12.87% while in the past one month the stock has lost 9.21%. Over the last three months the stock has declined 9.03% and in the past six months the shares have registered a loss of 0.83%. The stock traded below its 200-day moving average of USD 47.33. Further, the company is trading at a price to earnings ratio of 7.56 and a price to book ratio of 2.57. Moreover, the stock is trading at a price to cash flow ratio of 8.71.
- Given recent events, DOW should be prioritized for another round of review.
Analyst Notes on BMY
- Bristol-Myers Squibb Co.'s stock increased by 2.12% to close Wednesday's session at USD 60.12, below its 50-day and 200-day moving averages of USD 65.13 and USD 64.17, respectively. The company's shares fluctuated in the range of USD 57.94 and USD 60.18. A total of 11.15 million shares exchanged hands, which surpassed its 50-day daily average volume of 6.77 million shares. Over the last three days Bristol-Myers Squibb Co.'s shares have declined by 3.28% and in the past one week the shares have moved down 2.58%. Furthermore, over the last three months the stock has lost 8.38% and in the past six months the shares have shed 7.59%. Further, the company is trading at a price to earnings ratio of 61.98. Additionally, the stock is trading at a price to cash flow ratio of 30.31 and a price to sales ratio of 5.93
- In consideration of the above, BMY is earmarked for further due diligence and is of particular interest.
Analyst Notes on LLY
- Eli Lilly and Co.'s stock slipped by 0.28% to close Wednesday's session at USD 76.09. The stock closed below its 50-day and 200-day moving averages of USD 82.49 and USD 82.94, respectively. The share price oscillated between USD 74.18 and USD 77.55. The stock recorded a trading volume of 6.97 million shares, which was above its 50-day daily average volume of 4.80 million shares. Over the last five days Eli Lilly and Co.'s shares have declined by 6.93% and in the past one month the stock has lost 9.70%. In addition, over the last three months the stock has lost 6.12% and year to date the shares have shed 9.70%. Further, the company is trading at a price to earnings ratio of 33.67 and a price to book ratio of 5.57. Additionally, the stock is trading at a price to cash flow ratio of 24.37 and a price to sales ratio of 4.24
- As a result, LLY has been placed on a watch-list for future positive developments.
Complementary Research Updates
To keep up to date with the discovery of emerging opportunity in today's market, take advantage of Trader's Choice tried and true newsletter on a complementary subscription basis: http://traders-choice.com/freevip
About Trader's Choice:
Trader's Choice ("TC") produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. TC has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.
TC has not been compensated; directly or indirectly; for producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer"). The Reviewer has reviewed and revised the content, as necessary, based on sound investment judgment and publicly available information which is believed to be reliable. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer (collectively referred to as the "Production Team") in any way. The Production Team is compensated on a fixed monthly basis and do not hold any positions of interest in any of the securities mentioned herein. The information in this release has been sourced from a third party data base.
NO WARRANTY
TC, the Author and the Reviewer (collectively referred to as the "Publishers") are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by the Publishers whatsoever for any direct, indirect or consequential loss arising from the use of this document. The Publishers expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, the Publishers do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither TC nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.traders-choice.com/.
RESTRICTIONS
TC is not available to residents of Belarus, Cuba, Canada, Iran, North Korea, Sudan, Syria or Somalia.
CONTACT
For any questions, inquiries, or comments reach out to us directly at:
E-mail: press (at) traders-choice.com
SOURCE: Trader's Choice
